ACR 2022 Tweet by TheDaoIndex
Tweet
Related Content
Researchers from the University of Pennsylvania have published an open-access review of dermatomyositis (DM) - its manifestations, hallmark cutaneous features, etiopathogenesis and treatment options.
After years of inactivity, therapeutic development for dermatomyositis has begun to move forward with several new therapies and therapeutic strategies."This is a very exciting time for the field because we're finally going to get some new treatments, and I think it will be helpful in our…
Dr. Jack Cush reviews this week's news from RheumNow.com, including: placebo trumps controversial therapies, the dynamics of disease activity, fuse the big toe, and patients don’t appreciate being told “it's all in your head”!Single center study of Probiotics in #PsA showed no benefit. 66…
